Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer 11/19/2018 Medications, GOTHENBURG, Sweden, November 15, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL)...
Study examines for risk factors associated with initiation of substance use 08/08/2018 Health News, Not all individuals who initiate use of a substance such as nicotine, alcohol, cannabis, and...
Vidac Pharma Announces Initiation of Phase 2b Clinical Trial of VDA-1102 Ointment in Patients with Actinic Keratosis 07/13/2018 Medications, Jerusalem, Israel, July 10 2018 – Vidac Pharma, a clinical stage oncology and dermatology focused...